文献速递腹部泌尿生殖CTMR

基于AJCC第8版肾细胞癌临床分期与再分期的影像学作用更新

Update on the Role of Imaging in Clinical Staging and Restaging of Renal Cell Carcinoma Based on the AJCC 8th Edition, From the AJR Special Series on Cancer Staging.
PubMed 文献 · AJR Am J Roentgenol · 2021-03-24

本文综述影像学在肾细胞癌临床分期与再分期中的核心作用。推荐对不确定肾肿块行平扫加增强肾脏CT或MRI以完整表征和分期;依据TNM系统需评估肿瘤大小、肾窦脂肪侵犯、集合系统侵犯、肾周脂肪侵犯、静脉侵犯、肾上腺侵犯、Gerota筋膜侵犯、邻近器官侵犯、区域淋巴结肿大及远处转移。影像准确分期与再分期可提供预后信息并指导最佳治疗。

要点

  • 不确定肾肿块推荐行平扫加增强肾脏CT或MRI以完整表征和分期。
  • TNM分期需评估肿瘤大小、肾窦脂肪、集合系统、肾周脂肪、静脉、肾上腺、Gerota筋膜、邻近器官侵犯及淋巴结和远处转移。
  • 肿瘤越大与更高分期、侵袭性、淋巴结播散及远处转移相关。

关键影像表现/征象

  • 评估不确定肾肿块或已知肾细胞癌需关注肿瘤大小、肾窦脂肪侵犯、集合系统侵犯、肾周脂肪侵犯、静脉侵犯、肾上腺侵犯、Gerota筋膜侵犯及邻近器官侵犯。
  • 需评估区域(腹膜后)淋巴结是否肿大或病理性以及是否存在远处转移。
  • 较大肿瘤尺寸与更高分期疾病及侵袭性、淋巴结播散和远处转移相关。

临床应用与阅片要点

  • 对不确定肾肿块行平扫加增强肾脏CT或MRI以完整表征和分期。
  • 依据TNM系统逐项评估上述关键侵犯部位及淋巴结和远处转移情况。
  • 关注晚期肾细胞癌对抗血管生成治疗和免疫治疗的反应表现,以及靶向治疗后肿瘤大小变化的局限性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This article reviews the essential role of imaging in clinical staging and restaging of renal cell carcinoma (RCC). To completely characterize and stage an indeterminate renal mass, renal CT or MRI without and with IV contrast administration is recommended. The critical items for initial clinical staging of an indeterminate renal mass or of a known RCC according to the TNM staging system are tumor size, renal sinus fat invasion, urinary collecting system invasion, perinephric fat invasion, venous invasion, adrenal gland invasion, invasion of the perirenal (Gerota) fascia, invasion into other adjacent organs, the presence of enlarged or pathologic regional (retroperitoneal) lymph nodes, and the presence of distant metastatic disease. Larger tumor size is associated with higher stage disease and invasiveness, lymph node spread, and distant metastatic disease. Imaging practice guidelines for clinical staging of RCC, as well as the role of renal mass biopsy, are highlighted. Specific findings associated with response of advanced cancer to antiangiogenic therapy and immunotherapy are discussed, as well as limitations of changes in tumor size after targeted therapy. The accurate clinical staging and restaging of RCC using renal CT or MRI provides important prognostic information and helps guide the optimal management of patients with RCC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Elkassem AA, Allen BC, Sharbidre KG, et al. Update on the Role of Imaging in Clinical Staging and Restaging of Renal Cell Carcinoma Based on the AJCC 8th Edition, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol. 2021. PMID: 33759558. doi:10.2214/AJR.21.25493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。